IBD-SDM Telemonitoring Interview
A Qualitative Study on Shared Decision Making in the Choice to Use Telemonitoring in the Management of Inflammatory Bowel Disease
1 other identifier
observational
17
1 country
2
Brief Summary
Introduction: Telemedicine has shown to play a promising role in enhancing patient care. Moreover, it is a key component of the Integraal Zorgakkoord (IZA), facilitating more efficient and accessible healthcare through telemonitoring and digital health innovations. However, it remains uncertain how Shared Decision Making (SDM) plays a role in the choice of telemedicine. Research focuses on technological capabilities or general patient-centredness, rather than how to effectively integrate SDM into decisions about using telemonitoring versus standard care. The integration of SDM into telemonitoring remains fragmented, suggesting that current SDM frameworks have not been adapted to the shift to telemedicine. If SDM is not achieved in this decision a decrease of adherence and engagement may follow. Research question: The aim of this qualitative study is to get a better understanding of role of SDM in the choice of telemonitoring or standard care. These insights could help to offer improvements to SDM in IBD care to patients. This led to the following research questions: 1\. How to optimize the decision-making process for patients with inflammatory bowel disease in the decision for telemonitoring? 1.1 How do patients and healthcare professionals perceive the current SDM within care processes for IBD? Study design: This is a qualitative study using semi-structured interviews. Information about patient's and professionals' experiences and preferences about SDM will be collected. To guide the topics in the interview, two theories/models will be used:
- 1.The Three-Talk Model
- 2.AAMC Telehealth Competencies Data will be analysed using thematic analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 20, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedSeptember 4, 2025
August 1, 2025
2 months
August 20, 2025
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Explorative Data
Based on topics derived from the three talk model and the AAMC Telehealth competencies. This data is evaluated with the semi-structured interviews
Through study completion, an average of 2 months
Study Arms (2)
Healthcare providers
Interviews with healthcare providers
Patients
Interviews with patiens
Interventions
Eligibility Criteria
The study population comprises adult (≥18 years) IBD patients and IBD healthcare professionals at JBZ and Franciscus who have experienced making a choice about telemonitoring. These hospitals are teaching institutions with a combined patient population of approximately 4000 individuals.
You may qualify if:
- Age \> 18 years
- Confirmed IBD diagnosis
You may not qualify if:
- Non
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Franciscus Gasthuislead
- Jeroen Bosch Ziekenhuiscollaborator
Study Sites (2)
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, 5223GZ, Netherlands
Franciscus
Rotterdam, 3045PM, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tessa EH Römkens, MD PhD
Jeroen Bosch Ziekenhuis
- PRINCIPAL INVESTIGATOR
Rachel L West, MD PhD
Franciscus Gasthuis
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2025
First Posted
September 4, 2025
Study Start
April 7, 2025
Primary Completion
June 6, 2025
Study Completion
July 1, 2025
Last Updated
September 4, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share